Masatoshi Hirayama

Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS

Yoshihiro Yoshitake, Daiki Fukuma, Akira Yuno et al. · Clinical Cancer Research · 2014 · 153 citations · Full text

Medicine, Immunology, Oncology +17

Identification of Promiscuous KIF20A Long Peptides Bearing Both CD4+ and CD8+ T-cell Epitopes: KIF20A-Specific CD4+ T-cell Immunity in Patients with Malignant Tumor

Yusuke Tomita, Akira Yuno, Hirotake Tsukamoto et al. · Clinical Cancer Research · 2013 · 74 citations

Life Sciences, Immunology, Oncology +17

Soluble IL6R Expressed by Myeloid Cells Reduces Tumor-Specific Th1 Differentiation and Drives Tumor Progression

Hirotake Tsukamoto, Koji Fujieda, Masatoshi Hirayama et al. · Cancer Research · 2017 · 52 citations

Life Sciences, Immunology, Oncology +14

HMGA2 Contributes to Distant Metastasis and Poor Prognosis by Promoting Angiogenesis in Oral Squamous Cell Carcinoma

Junki Sakata, Akiyuki Hirosue, Ryoji Yoshida et al. · International Journal of Molecular Sciences · 2019 · 42 citations · Full text

Medicine, Cancer Biology, Oncology +17

Extracellular vesicles derived from radioresistant oral squamous cell carcinoma cells contribute to the acquisition of radioresistance via the miR‐503‐3p‐BAK axis

K. Yamana, Junki Inoue, Ryoji Yoshida et al. · Journal of Extracellular Vesicles · 2021 · 41 citations · Full text

Medicine, Cancer Biology, Oncology +17